9th September 2020

🗞️ Much needed calm after the storm

Surveying the damage… Markets finally got some respite and managed to put up a decent rally. There was a tinge of disappointment coming from the news that AstraZeneca had paused phase 3 COVID-19 clinical trials following an adverse reaction in one of the study’s participants. The company’s drug development (with Oxford University) was (and still […]
Subscribers can log in to continue reading. Otherwise, purchase The Monthly Access Pass or One Year Subscription to become a subscriber.

Suki Mann

A 30+ year veteran of the European corporate bond markets and in his role as Credit Strategist, Dr Mann has been ranked number one in the Euromoney Investor Survey eight times in ten years. Previously with Societe Generale and UBS, he now shares views of events in the corporate bond market exclusively here on CreditMarketDaily.com.